Alua Capital Management’s Cardlytics CDLX Stock Holding History

Alua Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-32,090	Closed	-$2.03M	–	24
2023 Q2	$2.03M	Hold	32,090	–	–	0.14%	21
2023 Q1	$1.09M	Sell	32,090 -45,985	-59%	-$2.4M	0.09%	21
2022 Q4	$4.51M	Sell	78,075 -55,761	-42%	-$3.44M	0.39%	20
2022 Q3	$12.6M	Hold	133,836	–	–	1.03%	21
2022 Q2	$29.9M	Hold	133,836	–	–	2.6%	13
2022 Q1	$73.6M	Buy	133,836 +9,410	+8%	+$5.69M	5.03%	10
2021 Q4	$82.2M	Hold	124,426	–	–	4.46%	9
2021 Q3	$104M	Hold	124,426	–	–	5.39%	8
2021 Q2	$158M	Buy	124,426 +7,400	+6%	+$8.35M	8.23%	6
2021 Q1	$128M	Buy	117,026 +25,000	+27%	+$33M	7.24%	6
2020 Q4	$131M	Buy	+92,026	New	+$98.2M	9.19%	6

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alua Capital Management's CDLX Position: Q3 2023 in Review

Alua Capital Management sold out of Cardlytics (CDLX) in Q3 2023, closing a stake of 32,090 shares — an estimated $2.03M sold.

Alua Capital Management first reported a position in CDLX in Q4 2020 and held it in 11 quarters. The position peaked at $158M in Q2 2021. 112 funds tracked by Wall St. Rank hold CDLX as of Q3 2023.

Alua Capital Management reported no remaining Cardlytics position as of Q3 2023 after selling out during the quarter.
Alua Capital Management sold 32,090 Cardlytics shares in Q3 2023, an estimated $2.03M.
Alua Capital Management first reported a position in Cardlytics in Q4 2020 and held it in 11 quarters.
Alua Capital Management's Cardlytics position peaked at $158M in Q2 2021.
112 funds tracked by Wall St. Rank held Cardlytics as of Q3 2023.

Based on Alua Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.